Clinical Trial Update: Apotransferrin in Atransferrinemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is assessing apotransferrin for congenital atransferrinemia; the study status is ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Atransferrinemia

Drugs mentioned

• Apotransferrin (apotransferrin)

Snippet

Sponsor: Prothya Biosolutions | Conditions: Congenital Atransferrinemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING